Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

NCT02657330 is registered in ClinicalTrials.gov with Panbela Therapeutics, Inc. as lead sponsor.

NCT NCT02657330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Lead sponsor
Panbela Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2016
Completion date
October 31, 2017
Enrollment
29 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ductal adenocarcinoma of the pancreas, pancreatic cancer